Pathogenicity of Candida albicans with particular reference to the vagina.
D000268:Adhesiveness; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002176:Candida albicans / Q000254:growth & development / Q000276:immunology / Q000378:metabolism / Q000472:pathogenicity*; D002181:Candidiasis, Vulvovaginal / Q000209:etiology / Q000276:immunology / Q000382:microbiology*; D002352:Carrier Proteins / Q000378:metabolism; D004848:Epithelium / Q000382:microbiology; D005260:Female; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000382:microbiology; D011374:Progesterone / Q000378:metabolism; D011372:Progestins / Q000494:pharmacology; D014621:Vagina / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D002352:Carrier Proteins; D011372:Progestins; D011374:Progesterone